Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure

Clinical Science

Volumn 110, Issue 4, 2006, Pages 491-501

  Pedersen, Erling B ^a,b   Bacevicius, Egidijus ^a   Bech, Jesper N ^a   Solling, Karsten ^c   Pedersen, Henrik B ^d  

^a HOLSTEBRO HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c HOLBÆK HOSPITAL   (Denmark)

^d MAX PLANCK INSTITUT FÜR KERNPHYSIK   (Germany)

Author keywords

Atrial natriuretic peptide (ANP); Brain natriuretic peptide (BNP); Chronic renal failure; Dialysis; Fourier transformation; Indomethacin; Pulsatile secretion

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; INDOMETACIN; PLACEBO; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DIALYSIS; FEMALE; FOURIER TRANSFORMATION; HUMAN; HYPOTHESIS; MALE; OSCILLATION; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; AGED; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; FEMALE; HEART RATE; HUMANS; INDOMETHACIN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SECRETORY RATE;

EID: 33645559415     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050336     Document Type: Article

References (31)

1. Ishizaka, Y., Yamamoto, Y., Fukunaga, T. et al. (1994) Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am. J. Kidney Dis. 24, 461-472
2. Akiba, T., Tachibana, K., Togashi, K., Hiroe, M. and Marumo, F. (1995) Plasma human brain natriuretic peptide in chronic renal failure. Clin. Nephrol. 44 (Suppl. 1) S61-S64
3. Nishikimi, T., Futoo, Y., Tamano, K. et al. (2001) Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am. J. Kidney Dis. 37, 1201-1208
4. Corboy, J. C., Walker, R. J., Simmonds, M. B., Wilkins, G. T., Richards, A. M. and Espiner, E. A. (1994) Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin. Sci. 87, 679-684
5. Takahashi, M., Nagake, Y., Ichikawa, H. et al. (1996) Plasma concentrations of natriuretic peptides in patients on hemodialysis, Res. Commun. Mol. Pathol. Pharmacol. 92, 19-30
6. Clerico, A., Caprioli, R., Del Ry, S. and Giannessi, D. (2001) Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J. Endocrinol. Invest. 24, 24-30
7. Haug, C., Metzele, A., Steffgen, J. and Grunert, A. (1994) Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Horm. Metab. Res. 26, 246-249
8. Cataliotti, A., Malatino, L. S., Jougasaki, M. et al. (2001) Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin. Proc. 76, 1111-1119
9. Goto, T., Takase, H., Toriyama, T. et al. (2002) Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92, 610-615
10. Naganuma, T., Sugimura, K., Wada, S. et al. (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am. J. Nephrol. 22, 437-444
11. Takami, Y., Horio, T., Iwashima, Y. et al. (2004) Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am. J. Kidney Dis. 44, 420-428
12. Carr, S. J., Bavanandan, S., Fentum, B. and Ng, L. (2005) Prognostic potential of brain natriuretic peptide (BNP) in preanalysis chronic kidney disease patients. Clin. Sci. 109, 75-82
13. Safley, D. M., Awad, A, Sullivan, R. A. et al. (2005) Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv. Chronic Kidney Dis. 12, 117-124
14. Zoccali, C., Mallamaci, F., Benedetto, F. A. et al. (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J. Am. Soc. Nephrol. 12, 1508-1515
15. Mallamaci, F., Zoccali, C., Tripepi, G. et al. (2001) The Cardiovascular Risk Extended Evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 59, 1559-1566
16. Pedersen, E. B., Pedersen, H. B. and Jensen, K. T. (1999) Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin. Sci. 97, 201-206
17. Haak, T., Jungmann, E. and Schooling, K. (1990) 24-h variation in atrial natriuretic peptide. Lancet 335, 167-168
18. Nugent, A. M., Onuoka, G. N., McEneaney, D. J. et al. (1994) Variable patterns of atrial natriuretic peptide secretion in man. Eur. J. Clin. Invest. 24, 267-274
19. Bentzen, H., Pedersen, R. S., Pedersen, H. B., Nyvad, O., Pedersen, E. B. et al. (2003) Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure. Clin. Sci. 104, 303-312
20. Nielsen, C. B., Bech, J. N. and Pedersen, E. B. (1996) Epoprostenol increases plasma levels of atrial natriuretic peptide in humans. Clin. Sci. 90, 87-89
21. Thomassen, A. R., Bagger, J. P., Nielsen, T. T. and Pedersen, E. B. (1987) Atrial natriuretic peptide during passing in controls and patients with coronary arterial disease. Int. J. Cardiol. 17, 267-276
22. Jensen, K. T., Carstens, J., Ivarsen, P. and Pedersen, E. B. (1997) A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand. J. Clin. Lab. Invest. 57, 529-540
23. Marshall, A. G. and Verdun, F. R. (1990) In Fourier Transforms in NMR, Optical, and Mass Spectroscopy, Elsevier, Amsterdam
24. Lang, D. A., Matthews, D. R., Burnett, M., Ward, G. M. and Turner, R. C. (1982) Pulsatile, synchronous basal insulin and glucagon secretion in man. Diabetes 31, 22-26
25. Brabrant, G. A., Brabrant, A., Ranft, U. et al. (1987) Circadian and pulsatile thyreotropia secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J. Clin. Endocrinol. Metab. 65, 83-88
26. Onuoha, G. N., Nugent, A. M., Hunter, S. J. et al. (2000) Neuropeptide variability in man. Eur. J. Clin. Invest. 30, 570-577
27. Chappell, P. E. (2005) Clocks and the black box: circadian influences on gonadotropin-releasing hormone secretion. J. Neuroendocrinol. 17, 119-130
28. Young, E. A., Abelson, J. and Lightman, S. L. (2004) Cortisol pulsatility and its role in stress regulation and health. Front. Neuroendocrinol. 25, 69-76
29. Tsutamoto, T., Wada, A., Maeda, K. et al. (1997) Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am. Heart. J. 134, 910-916
30. Hara, Y., Hamada, M., Shigematsu, Y. et al. (2000) Effects of β-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn Circ. J. 64, 365-369
31. Deary, A. J., Schumann, A. L., Murfet, H., Haydock, S., Foo, R. S. and Brown, M. J. (2002) Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin. Sci. 103, 493-499